PMID: 6988263Jan 1, 1980Paper

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment

Diabetologia
K KosakaR Hagura

Abstract

The changes in insulin response to a 100 g glucose tolerance test after treatment by diet, sulphonylurea and insulin were compared in non-ketotic diabetic patients who had fasting blood glucose concentrations higher than 160 mg/100 ml. Patients were selected so that their pre-treatment and post-treatment blood glucose levels were comparable between different treatment groups. Their insulin responses were poor initially but increased significantly when the diabetic state was improved by each treatment. The degree of improvement of insulin response was similar between different treatment groups, when their fasting blood glucose decreased below 140 mg/100 ml and the glucose tolerance curves were improved to a similar extent. Pre- and post-treatment sigma IRI values (sum of insulin values during glucose tolerance test, mean +/- SD) were 102 +/- 50 and 200 +/- 37 microU/ml in diet-treated group (n = 28), 90 +/- 40 and 195 +/- 53 microU/ml in sulphonylurea-treated group (n = 48), and 83 +/- 28 and 193 +/- 38 microU/ml in insulin-treated group (n = 13), respectively. The data suggest that the poor insulin response in overt diabetes results not only from an inherent insensitivity of B-cells to glucose but also from the metabolic derang...Continue Reading

References

Oct 1, 1977·Endocrinologia Japonica·Y FukumotoS Tarui
Nov 9, 1978·Nature·M N Feinglos, H E Lebovitz
Nov 1, 1975·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D L HorwitzN Yanaihara
Mar 11, 1976·The Journal of Clinical Investigation·R P RobertsonD Porte
Feb 11, 1976·The Journal of Clinical Endocrinology and Metabolism·J D BrunzellD Porte
Sep 1, 1972·The Journal of Clinical Endocrinology and Metabolism·M B BlockA H Rubenstein
Mar 1, 1969·Archives of Internal Medicine·J M Feldman, H E Lebovitz
Nov 1, 1972·The Journal of Clinical Endocrinology and Metabolism·K KosakaT Kuzuya
May 1, 1970·The American Journal of Physiology·H SandoT Kuzuya
Aug 1, 1966·The American Journal of Physiology·Y KanazawaK Kosaka

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Cellular Biochemistry·G M Grodsky, J L Bolaffi
Jan 1, 1982·European Journal of Clinical Pharmacology·E J AntalK S Albert
Apr 1, 1984·Acta diabetologica latina·M CignarelliR Giorgino
Jul 24, 2010·Current Atherosclerosis Reports·Patrick MurrayVasudevan A Raghavan
Sep 17, 2003·Current Diabetes Reports·Afshin Sasali, Jack L Leahy
Nov 1, 1991·Archives of Gerontology and Geriatrics·A QuatraroD Giugliano
Jun 1, 2005·Archives of Medical Research·Jack L Leahy
Jun 17, 2003·Disease-a-month : DM·Rasa Kazlauskaite, Leon Fogelfeld
Jul 22, 1999·Diabetes Research and Clinical Practice·K TanakaY Yajima
Jun 20, 2001·Acta Physiologica Scandinavica·C G Ostenson
Sep 14, 2001·Journal of Internal Medicine·T YamadaK Hashizume
Jul 29, 1982·The New England Journal of Medicine·W M RuppH Buchwald
May 15, 1986·The New England Journal of Medicine·D B Martin
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A StarkeR H Unger
Aug 1, 1993·Journal of Internal Medicine·S Efendic, C G Ostenson
Sep 1, 1994·Journal of Internal Medicine·L NiskanenM Uusitupa
Oct 1, 2011·Diabetes, Obesity & Metabolism·R A DeFronzoS Del Prato
Jul 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·J P HoskerA J Boulton
Jul 19, 2006·International Journal of Clinical Practice·S BruceH C S Howlett
Oct 1, 1987·The Journal of Clinical Investigation·L RossettiR A DeFronzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.